Patents by Inventor Said Al-Jaroudi

Said Al-Jaroudi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating prostate cancer and/or gastrointestinal cancer
    Patent number: 9649292
    Abstract: Gold(III) complexes having mixed ligands as anticancer agents. The gold(III) complexes are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and an ethylenediamine ligand. These complexes can exist in both cis- and trans-configurations. Also described are pharmaceutical compositions incorporating the gold(I) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: May 16, 2017
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Said Al-Jaroudi, Muhammad Altaf, Abdulaziz Al-Saadi, Anvarhusein Abdulkadir Isab
  • METHOD FOR TREATING PROSTATE CANCER AND/OR GASTROINTESTINAL CANCER
    Publication number: 20170100365
    Abstract: Gold(III) complexes having mixed ligands as anticancer agents. The gold(III) complexes are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and an ethylenediamine ligand. These complexes can exist in both cis- and trans-configurations.
    Type: Application
    Filed: September 30, 2016
    Publication date: April 13, 2017
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Said AL-JAROUDI, Muhammad ALTAF, Abdulaziz AL-SAADI, Anvarhusein Abdulkadir ISAB
  • METHOD FOR TREATING A CANCER WITH A MIXED LIGAND GOLD(III) COMPLEXES AS ANTI-CANCER AGENTS
    Publication number: 20170071893
    Abstract: Gold(III) complexes with mixed ligands as anticancer agents. The gold(III) cations are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and a 1,3-propylenediamine ligand. The diaminocyclohexane ligand can exist in both cis- and trans-configurations, resulting in isomeric gold(III) complexes. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.
    Type: Application
    Filed: September 30, 2016
    Publication date: March 16, 2017
    Applicant: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
    Inventors: Said AL-JAROUDI, Muhammad ALTAF, Abdulaziz AL-SAADI, Anvarhusein Abdulkadir ISAB
  • Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents
    Patent number: 9585861
    Abstract: Gold(III) complexes with mixed ligands as anticancer agents. The gold(III) cations are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and a 1,3-propylenediamine ligand. The diaminocyclohexane ligand can exist in both cis- and trans- configurations, resulting in isomeric gold(III) complexes. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: March 7, 2017
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Said Al-Jaroudi, Muhammad Altaf, Abdulaziz Al-Saadi, Anvarhusein Abdulkadir Isab
  • Mixed ligand gold(III) complexes and methods thereof
    Patent number: 9487542
    Abstract: Gold(III) complexes having mixed ligands as anticancer agents. The atom is coordinated by bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and an ethylenediamine ligand. These complexes can exist in both cis- and trans-configurations. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: November 8, 2016
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Said Al-Jaroudi, Muhammad Altaf, Abdulaziz Al-Saadi, Anvarhusein Abdulkadir Isab
  • Mixed ligand gold(III) complexes as anti-cancer agents
    Patent number: 9481693
    Abstract: Gold(III) complexes with mixed ligands as anticancer agents. The gold(III) cations are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and a 1,3-propylenediamine ligand. The diaminocyclohexane ligand can exist in both cis- and trans-configurations, resulting in isomeric gold(III) complexes. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: November 1, 2016
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Said Al-Jaroudi, Muhammad Altaf, Abdulaziz Al-Saadi, Anvarhusein Abdulkadir Isab